Table 2.
Characteristics and main findings of clinical remote IPC studies
| First author [ref.], year | RIPC group vs. controls, n | RIPC settings | Main findings |
|---|---|---|---|
| Robertson [24] 2017 |
20 vs. 20 | Donor: deceased | RIPC is feasible and acceptable in liver transplant recipients |
| Applied to: recipient | |||
| Place: left middle thigh | No differences in clinical outcomes between RIPC and control groups | ||
| Applied pressure: 200 mm Hg | |||
| Time: 3 cycles of 5 min each of | Lower median IL-6 level in the preconditioned group compared to controls | ||
| ischemia and reperfusion | |||
|
| |||
| Jung [25] 2020 |
75 vs. 73 | Donor: living | No beneficial effect to the donor |
| Applied to: donor | Significantly lower AST levels on postoperative days 1 and 7 in recipients with preconditioned grafts | ||
| Place: upper arm | |||
| Applied pressure: 200 mm Hg | |||
| Time: 3 cycles of 5 min each of ischemia and reperfusion | |||